WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
HIV drug resistance , Users Manual
December 2017
UNAIDS/WHO 2015 | Reference
Guidelines
June 2017
HIV strategic information for impact
PQDx 0144-043-00 WHO
PQDx Public Report
November/2016, version 4.0
PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
Guidelines
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
August 2015
HIV strategic information for impact
12-13 December 2016
Global Action Plan on HIV Drug Resistance - Webinars 12-13 December 2016
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
8th IAS Conference on HIV Pathogenesis 19-22 July 2015 Vancouver
Anita Sands Prequalification Team – Diagnostics Essential Medicines and Health Product